原发性肝癌介入治疗结合三维适形放射治疗疗效观察

The Efficiency of Primary Hepatic Carcinoma using Transcatheter Arterial Chemoembolization combine Three-dimension right Shape

目的：评价肝动脉化疗栓塞（TACE）结合三雏适形放射治疗（3D—CRT）对原发性肝癌（PHC）的疗效。方法：对10例不能手术切除的原发性肝癌患者，采用先TACE后3D—CRT相结合，观察疗效及生存率，10例中单发病灶6例，多结节痛灶4例。TACE1次者5例，2～3次以上者5例。放射治疗剂量54～64GY。单次分割剂量3～5GY。结果：治疗后1年、两年的肿呐局部有效率分别为90％、65％。1-2年生存率分别为90％、30％，中位生存期15个月。结论：TACE结合3D—CRT是治疗PHC的有效无创治疗手段。

Objective： To evaluate efficiency of primary hepatic carcinoma （ PHC ） using transcatheter arterial chemoembolization （TACE ） combine three -dimension right shape. Method： Ten patients with unreseetable HCC adopt three- dimension right shape after the TACE first, observing curative effect and survival rate. 6 of 10 is one focus, 4 of 10 have more. 5 patients adopted TACE 1 time , patients adopted TA- CE more than 1 times is five. delivered dose of 53 - 60Gy. Result： One year after treating finally, the partly effective was 90. %. ,65%. 1 - 2 years survival rate respectively is 90% ,30%. median life span is 15 months. Conclusion： To treat PHC with TACE combine three - dimension right shape is an effectively and no insult method.